|
SocialPicks Sentiment:
N/A
** not enough data to be rated
|
This Quarter's Sentiment:
|
|
|
|
|
|
An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to treat. To read about whether this small cap company has chances to get their drug approved, get a FREE report at: http://www.newbiomedicine.com
... more »
|
|
|
|
|
An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to treat. To read about whether this small cap company has chances to get their drug approved, get a FREE report at: http://www.newbiomedicine.com
... more »
|
|
|
|
|
FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by the FDA will increase significantly. If the drug gets approved by the FDA, it is estimated to achieve Peak sales of $350 million. To read about our ex...
... more »
|
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on AFFY |
Visit streetinsider.com
More Resources
|
About Affymax Inc.
- Answers.com
